HSIA DAVID C 4
4 · WATSON PHARMACEUTICALS INC · Filed Aug 11, 2004
Insider Transaction Report
Form 4
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
- Award
Stock Options to Purchase Common Stock
2004-08-09+16,000→ 16,000 totalExercise: $26.14From: 2005-08-09Exp: 2014-08-09→ Common Stock, par value $0.0033 (16,000 underlying)
Holdings
- 579,064(indirect: By Trust)
Common Stock, par value $0.0033
- 1,024,218(indirect: By Partnership)
Common Stock, par value $0.0033
- 40,000(indirect: By Trust)
Common Stock, par value $0.0033
- 260,000
Common Stock, par value $0.0033
Footnotes (2)
- [F1]The options are to be incentive stock options to the extent permitted by law, and thereafter to be non-statutory stock options.
- [F2]These stock options become exercisable in five annual installments of 3,200 each commencing on August 9, 2005.